Page last updated: 2024-08-23

simvastatin and Cancer, Second Primary

simvastatin has been researched along with Cancer, Second Primary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colquhoun, D; Hamilton-Craig, I; Kostner, K; Woodhouse, S1

Other Studies

1 other study(ies) available for simvastatin and Cancer, Second Primary

ArticleYear
At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.
    Heart, lung & circulation, 2009, Volume: 18, Issue:5

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Azetidines; Cholesterol; Drug Therapy, Combination; Endpoint Determination; Ezetimibe; Female; Humans; Lipoproteins, LDL; Male; Neoplasms, Second Primary; Randomized Controlled Trials as Topic; Simvastatin

2009